BioCentury
ARTICLE | Company News

Accentia, Mayo Foundation for Medical Education and Research deal

May 21, 2007 7:00 AM UTC

The foundation received a $125,000 milestone payment from ABPI triggered by the start of a Phase III trial of SinuNase intranasal amphotericin B to treat chronic sinusitis (see BioCentury, Nov. 13, 20...